News Conference News ESC 2021 PRONOUNCE: No Difference in CVD Risks With Degarelix and Leuprolide for Prostate Cancer Michael O'Riordan August 30, 2021
News Daily News Rivaroxaban Safe, Effective in Renal Disease: VOYAGER PAD L.A. McKeown August 10, 2021
News Daily News Coffee Doesn’t Disturb Heart Rhythm: UK Biobank Analysis Caitlin E. Cox July 22, 2021
News Conference News ACC 2021 Rivaroxaban Helps Prevent More Events Than Aspirin Alone After Leg Interventions L.A. McKeown May 21, 2021
News Conference News SCAI 2021 Compression Times Cut With Adjunctive Hemostatic Patch After Transradial Procedures Michael O'Riordan May 03, 2021
News Daily News Critical Limb Ischemia During COVID: Lessons for Care and Clinical Trials L.A. McKeown April 26, 2021
News Daily News Vascular Experts Say It’s Time to Let Paclitaxel Out of Regulatory Jail L.A. McKeown April 22, 2021
News Daily News LITE: High- Beats Low-Intensity Exercise at Home for Improving PAD L.A. McKeown April 09, 2021
News Daily News Mobile Tech May Boost CAD Secondary Prevention for Older Adults L.A. McKeown April 07, 2021
News Daily News Eating More Ultraprocessed ‘Junk’ Food Linked to Higher CVD Risk Michael O'Riordan March 23, 2021
News Daily News Rivaroxaban-Aspirin Combo Works in ASCVD Across BMI Groups Todd Neale February 01, 2021
News Daily News Vitamin D, Calcium, Other Vitamins, and Supplements Do Not Prevent CVD Michael O'Riordan January 25, 2021
News Daily News New Advanced Training Outlined for Future Vascular Medicine Specialists Michael O'Riordan January 21, 2021
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for December 2020 Shelley Wood December 31, 2020